CancerVax Corp.
CancerVax has developed a vaccine comprised of three irradiated melanoma cell lines that appear to be highly immunogenic and appear to cause an immune response in most patients with melanoma.
CancerVax has developed a vaccine comprised of three irradiated melanoma cell lines that appear to be highly immunogenic and appear to cause an immune response in most patients with melanoma.